Rodrigo A. Fraga‐Silva

École Polytechnique Fédérale de Lausanne

Papers

1

Total Citations

1

H-Index

1

About

Rodrigo A. Fraga-Silva is a pioneering researcher at the intersection of biomedical engineering and urological rehabilitation. His work focuses on developing innovative neurostimulation technologies to address erectile dysfunction (ED), particularly following radical prostatectomy—a common cancer treatment that often results in nerve damage. Fraga-Silva’s most notable contribution is the first-in-human implantable neurostimulator for erectile function rehabilitation, detailed in his 2024 study. This breakthrough device aims to restore erectile function by directly stimulating the cavernous nerves, offering hope to patients who currently face limited recovery options. While this work is still early-stage, its potential impact is profound, addressing a critical unmet need in post-prostatectomy care. Beyond this flagship achievement, Fraga-Silva’s research spans neural interfaces, bioelectronic medicine, and regenerative strategies for nerve repair. His interdisciplinary approach bridges engineering and clinical practice, with the goal of translating lab innovations into tangible patient benefits. As his work gains traction, it promises to redefine standards of care for erectile dysfunction, improving quality of life for millions of men worldwide.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
(023) FIRST-IN-HUMAN IMPLANTABLE NEUROSTIMULATOR FOR ERECTILE FUNCTION REHABILITATION POST-PROSTATECTOMY: EARLY RESULTS
1 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: École Polytechnique Fédérale de Lausanne

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago